Biolipox
Solna
About Biolipox
Biolipox is a research-intense pharmaceutical company that develops treatments for inflammatory diseases. This includes widespread diseases such as asthma, COPD, rhinitis, and inflammatory and rheumatic pain. The company offers its users with current arachidonic acid research. Arachidonic acid is an endogenous substance that plays a central role in the development of inflammatory diseases. It is an established research area that empowers several drugs such as Aspirin, Naproxen, and Singulair. Biolipox is a Sweden-based company that was founded in 2000 and the company was acquired by Orexo on November 23, 2007.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $62.0M
- Funding stage: M&A
- Last round: Series C (Jan 2005)
- Website: biolipox.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/biolipox-2443256 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.